Iovance Biotherapeutics, Inc.IOVANASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, below historical average, strong compound growth.
Left:
||||
Free cash flow yield
Latest
-16.97%
↓ 33% below average
Average (9y)
-12.74%
Historical baseline
Range
High:-3.93%
Low:-30.77%
CAGR
+12.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -16.97% | +15.5% |
| 2023 | -20.09% | +34.7% |
| 2022 | -30.77% | -239.4% |
| 2021 | -9.07% | -130.9% |
| 2020 | -3.93% | +18.5% |
| 2019 | -4.82% | +59.5% |
| 2018 | -11.90% | +22.1% |
| 2017 | -15.28% | -71.6% |
| 2016 | -8.90% | -56.3% |
| 2015 | -5.69% | - |